Pharmacokinetics of Itraconazole in Pediatric Cancer Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study investigated repeated-dose pharmacokinetics and safety of itraconazole and its
active metabolite hydroxyitraconazole in pediatric cancer patients at risk for the
development of invasive fungal disease.